EnBio Co. Ltd.
Enbio Co., Ltd. produces and sells pesticides in South Korea. It offers fungi-insecticides, fungicides, insecticides, herbicides, plant growth regulars, and fertilizers. The company was founded in 1997 and is headquartered in Gunpo-si, South Korea.
EnBio Co. Ltd. (352940) - Total Liabilities
Latest total liabilities as of June 2025: ₩25.93 Billion KRW
Based on the latest financial reports, EnBio Co. Ltd. (352940) has total liabilities worth ₩25.93 Billion KRW as of June 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
EnBio Co. Ltd. - Total Liabilities Trend (2017–2024)
This chart illustrates how EnBio Co. Ltd.'s total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
EnBio Co. Ltd. Competitors by Total Liabilities
The table below lists competitors of EnBio Co. Ltd. ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Santa Fe Minerals Ltd
AU:SFM
|
Australia | AU$210.23K |
|
Aqua Corporation Public Company Limited
BK:AQUA
|
Thailand | ฿3.40 Billion |
|
Andromeda Metals Limited
PINK:ANDMF
|
USA | $2.27 Million |
|
AIM Commercial Growth Freehold And Leasehold Real Estate Investment Trust
BK:AIMCG
|
Thailand | ฿498.60 Million |
|
Mason Capital Corporation
KQ:021880
|
Korea | ₩13.70 Billion |
|
Veranda Resort Public Company Limited
BK:VRANDA
|
Thailand | ฿3.91 Billion |
|
Bioray Biotech Co., Ltd
TWO:7561
|
Taiwan | NT$84.01 Million |
Liability Composition Analysis (2017–2024)
This chart breaks down EnBio Co. Ltd.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.06 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.59 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.37 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how EnBio Co. Ltd.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for EnBio Co. Ltd. (2017–2024)
The table below shows the annual total liabilities of EnBio Co. Ltd. from 2017 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | ₩26.40 Billion | +3.15% |
| 2023-12-31 | ₩25.59 Billion | -37.38% |
| 2022-12-31 | ₩40.87 Billion | +0.45% |
| 2021-12-31 | ₩40.69 Billion | +17.86% |
| 2020-12-31 | ₩34.52 Billion | +1.95% |
| 2019-12-31 | ₩33.86 Billion | -43.00% |
| 2018-12-31 | ₩59.40 Billion | +30.83% |
| 2017-12-31 | ₩45.41 Billion | -- |